(S)-3-((tert-Butoxycarbonyl)amino)pentanoic acid, 95.0%, 100mg

endo-BCN-O-PNB, 1g

4-[2-(1H-pyrazol-1-yl)ethyl]piperidine, 95.0%, 250mg

1-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1h-indol-1-yl]ethan-1-one, 95+%, 500mg

1-(3,5-DICHLOROPYRIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE, 95.0%, 1g

2-Nitro-5-(trifluoromethyl)phenylacetic acid, 97%, 5g

2-(3-Nitro-benzylsulfanyl)-ethylamine; hydrochloride, 95.0%, 1g

(R)-5-(Chloromethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one, 95.0%, 1g

5-Acetyl-2-fluorobenzonitrile, 95.0%, 1g

(S)-tert-Butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate, 95.0%, 250mg

4-Bromo-3-fluoro-N-methylaniline, 96.0%, 5g

1-(tert-Butyl) 2-methyl (2S,4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)pyrrolidine-1,2-dicarboxylate, 95%, 100mg

2-Methoxy-6-methylnicotinic acid, 98+%, 100mg